Clinical trial
Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance
NCT05764330 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance
- Lead sponsor
- Roswell Park Cancer Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 24, 2024
- Completion date
- June 30, 2025
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate carcinoma